NAT-BOSENTAN

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 31f8e4f2e0dcd348
Drug Approval Canada Name: NAT-BOSENTAN
Product Name: NAT-BOSENTAN
Status: Marketed
Status Date: 2020-04-30
Original Market Date: 2020-04-30
Din: 02467992
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 48:48.12
Atc Original: C02KX01 BOSENTAN
Atc Name: c 02 kx 01
Aig Number: 0145922002
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

BOSENTAN (BOSENTAN MONOHYDRATE)

125 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

31f8e4f2e0dcd348

Type

Standard